They found a significant higher ratio of HDL EPA/apolipoprotein B non-HDL and EPA/HDL EPA in the sera from Ki67−/HR− patients compared with Ki67+/HR− patients, suggesting a protective role of EPA carried by non-HDL particles in this subtype of breast cancer [119]. This evidence concerns the gene MKI67 and breast carcinoma.